Company Filing History:
Years Active: 2014
Title: Cornelia Irl: Innovator in Anti-Angiogenesis Therapy
Introduction
Cornelia Irl is a prominent inventor based in Basel, Switzerland. She has made significant contributions to the field of cancer treatment, particularly through her innovative work on anti-angiogenesis therapy.
Latest Patents
Cornelia Irl holds a patent for an anti-angiogenesis therapy aimed at treating ovarian cancer. This invention focuses on the treatment of diseases and pathological conditions using anti-VEGF antibodies. More specifically, it addresses the treatment of human patients who are susceptible to or diagnosed with cancer, utilizing an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents for the effective treatment of ovarian cancer.
Career Highlights
Cornelia Irl is associated with Genentech, Inc., a leading biotechnology company known for its innovative approaches to drug development. Her work has been instrumental in advancing therapeutic options for cancer patients.
Collaborations
Cornelia collaborates with various professionals in her field, including her coworker Jakob Dupont, to further enhance the impact of her research and inventions.
Conclusion
Cornelia Irl's contributions to anti-angiogenesis therapy represent a significant advancement in the treatment of ovarian cancer. Her innovative approach continues to inspire progress in cancer research and therapy.